Jan. 11, 2006 (San Francisco) — Intensivists may underuse the sedative/anesthetic agent dexmedetomidine ( Precedex; Abbott Laboratories) in the management of the intensive care patient who requires ...

Objectives: Although generally effective for sedation during noninvasive procedures, dexmedetomidine as the sole agent has not been uniformly successful for invasive procedures. To overcome some of ...

Heitor Medeiros, MD, and A. Sassan Sabouri, MD, of the Department of Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital, are the lead and corresponding authors, respectively ...

The FDA has approved Precedex (dexmedetomidine HCl, from Hospira) injection for the sedation of non-intubated patients prior to and/or during surgical and other procedures. This approval is based on ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, a medication for ...

Fresenius Kabi announced the launch of Dexmedetomidine Hydrochloride Injection, the generic version of Hospira‘s Precedex. Precedex is a selective alpha-2 adrenergic agonist. Approved by the FDA in ...

Due to their unpredictability and variable effects, injectable anesthetic regimens in laboratory rodent species warrant refinement. In our study we sought to evaluate alfaxalone, which has gained ...